Codes / ICD10CM / T36.3X1A

T36.3X1A Poisoning by macrolides, accidental (unintentional), initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by macrolides, accidental (unintentional), initial encounter

Summary

This condition describes accidental (unintentional) poisoning by macrolide antibiotics during an initial encounter. It includes cases where exposure to macrolides leads to harmful effects due to overdose or adverse reactions. Documentation should specify the type of macrolide, the accidental nature of the exposure, and that this is the initial encounter for management.

Causes

Accidental poisoning may result from unintentional overdose of macrolides, incorrect administration (e.g., dosing errors), or allergic reactions. It can occur due to medication mix-ups, pediatric ingestion of adult doses, or misinterpretation of dosing instructions. Adverse effects may stem from drug interactions, idiosyncratic reactions, or cumulative toxicity.

Risk Factors

  • Prior history of macrolide allergies or sensitivities.
  • Polypharmacy increasing interaction risks.
  • Renal or hepatic impairment affecting drug metabolism.
  • Pediatric or geriatric populations with altered pharmacokinetics.
  • Inadequate patient education on medication use.

Symptoms

  • Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
  • Allergic: Rash, urticaria, anaphylaxis.
  • Systemic: Fever, hypotension, organ dysfunction (e.g., hepatotoxicity).
  • Neurologic: Dizziness, confusion, or seizures in severe cases.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and potential exposure details. Laboratory tests may assess macrolide levels, organ function (e.g., liver/kidney), or allergic markers. Toxicology screening can confirm exposure, while imaging or other tests rule out complications.

Treatment Options

Treatment focuses on stabilizing the patient, removing unabsorbed drug (e.g., activated charcoal), and managing symptoms (e.g., antiemetics, antihistamines). Severe reactions may require supportive care (e.g., fluids, ventilation) or specific antidotes if available. Discontinuation of the macrolide is standard.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of treatment, and patient factors (e.g., organ function). Most accidental poisonings resolve with supportive care, but severe cases may have prolonged recovery. Follow-up includes monitoring for delayed effects and reassessing medication safety.

Complications

Potential complications include organ damage (e.g., hepatotoxicity, nephrotoxicity), severe allergic reactions (e.g., anaphylaxis), or persistent symptoms. In rare cases, overdose may lead to cardiovascular or respiratory instability.

Lifestyle & Prevention

Prevention involves proper medication storage (out of reach of children), clear dosing instructions, and patient education on macrolide use. Avoiding polypharmacy without provider oversight and verifying allergies can reduce risks.

When to Seek Professional Help

Seek immediate care for symptoms like difficulty breathing, swelling, severe vomiting, or altered consciousness. Prompt evaluation is critical for suspected macrolide poisoning to prevent complications.

Tips for Medical Coders

Use this code for accidental (unintentional) macrolide poisoning during the initial encounter. Document the macrolide type, accidental intent, and encounter details (e.g., initial vs. subsequent). Ensure specificity in clinical notes to support coding accuracy.

Book a walkthrough

T36.3X1A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.